APRE   $2.91  -5.35% Market Closed

Aprea Therapeutics Inc
Total Cash 28.69M
totalCashPerShare 5.283
EBITDA -14.18M
Total Debt 0.00
quickRatio 9.274
currentRatio 9.553
Total Revenue 1.28M
debtToEquity
Revenue/Share 0.29
ROA -0.30255
ROE -0.50108004
grossProfits
freeCashflow -9.36M
operatingCashflow -13.56M
earningsGrowth
revenueGrowth 1.249
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -6.8502502
profitMargins 0.0
enterpriseValue -10.82M
forwardPE -3.235294
floatShares 4.02M
sharesOutstanding 5.43M
sharesShort 13.16K
sharesShortPriorMonth 10.98K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.44%
Short Ratio help_outline 1.28%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 4.707
Price To Book help_outline 0.70
earningsQuarterlyGrowth
netIncomeToCommon -12.93M
trailingEps -3.01%
forwardEps -1.02%
enterpriseToEbitda 0.76
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.74 3Q 2024
institutionsCount 35
lastUpdated Oct. 16, 2024, 8:16 p.m.